REVERSE CONVERTIBLE - ABBVIE/AMGEN/CVS HEALTH | Market Closed - Swiss Exchange 11:20:00 2024-05-16 EDT | ||
| 93.02 EUR | +2.19% |
|
| 1 month | -6.63% | ||
| 3 months | -7.03% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-16 | 93.02 | +2.19% |
| 24-05-14 | 91.03 | -1.79% |
| 24-05-13 | 92.69 | +1.67% |
| 24-05-10 | 91.17 | +0.77% |
Delayed Quote Swiss Exchange
Last update May 16, 2024 at 11:20 am
More quotesStatic data
| Product type | Other Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | LEONTEQ |
| UYGLTQ | |
| ISIN | CH1194698051 |
| Date issued | 2022-06-17 |
| Maturity | 2024-06-17 (30 Days) |
| Parity | 1 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | both |
| Currency | EUR |
Technical Indicators
| Highest since issue | 103.3 € |
|---|---|
| Lowest since issue | 88.51 € |
| Spread | 8 € |
| Spread % | 0.85% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
312.5
USD
Average target price
314.1
USD
Spread / Average Target
+0.51%
- Stock Market
- Certificates
- UYGLTQ Certificat